Multiple Sclerosis and Demyelinating Disorders: Past, Present, and Future—2nd Edition
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".
Deadline for manuscript submissions: 30 May 2025 | Viewed by 286
Special Issue Editors
Interests: neuroscience; multiple sclerosis; demyelinating desease; neurology; neuroimmunology
Special Issues, Collections and Topics in MDPI journals
Interests: neurological diseases; multiple sclerosis; demyelinating diseases; neuroinflammation; neurodegenerative diseases
Special Issues, Collections and Topics in MDPI journals
Interests: neuroimaging; cognition disorders; multiple sclerosis; neuroimmunology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is our pleasure to invite you to contribute to the new volume of “Multiple Sclerosis and Demyelinating Disorders: Past, Present, and Future—2nd Edition”, following the success of the first Special Issue on this topic, collecting eight papers which can be found at https://www.mdpi.com/journal/jcm/special_issues/6M072GM8F0.
Recent advances in diagnostic procedures and therapeutic interventions in multiple sclerosis have substantially improved disease management and outcomes. During the last decade, the diagnostic criteria have been refined, allowing an earlier diagnosis, while preclinical conditions such as the radiologically isolated syndrome have been extensively studied. Current research efforts explore the feasibility of using advanced neuroimaging techniques and blood biomarkers, such as the levels of neurofilament light chains, in clinical practice. Future perspectives include the implementation of digital monitoring tools in everyday clinical practice, which may allow early detection and the prevention of disease worsening.
This Special Issue of the Journal of Clinical Medicine seeks commentaries, original research, short reports, and reviews focusing on advances in the research, diagnosis, monitoring, and treatment of multiple sclerosis and other demyelinating disorders such as neuromyelitis optica and MOG-associated diseases.
This Special Issue aims to provide information about advances in phenotyping people with demyelinating disorders, treatment personalization, and the long-term monitoring and management of these disease entities. We look forward to your contributions.
Prof. Dr. Nikolaos Grigoriadis
Dr. Maria Eleptheria Evangelopoulos
Dr. Christos Bakirtzis
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multiple sclerosis
- disease-modifying therapies
- neurodegeneration
- neuromyelitis optica
- disease monitoring
- diagnostic criteria
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
